3,561
Views
21
CrossRef citations to date
0
Altmetric
Report

Efficient generation of monoclonal antibodies from single rhesus macaque antibody secreting cells

, , , , , , , , , , , , , , , & show all
Pages 707-718 | Received 02 Apr 2015, Accepted 04 May 2015, Published online: 29 Jun 2015

References

  • Fellows PF, Linscott MK, Ivins BE, Pitt ML, Rossi CA, Gibbs PH, Friedlander AM. Efficacy of a human anthrax vaccine in guinea pigs, rabbits, and rhesus macaques against challenge by Bacillus anthracis isolates of diverse geographical origin. Vaccine 2001; 19:3241-7; PMID:11312020; http://dx.doi.org/10.1016/S0264-410X(01)00021-4
  • Ruiz W, McClements WL, Jansen KU, Esser MT. Kinetics and isotype profile of antibody responses in rhesus macaques induced following vaccination with HPV 6, 11, 16 and 18 L1-virus-like particles formulated with or without Merck aluminum adjuvant. J Immune Based Ther Vaccines 2005; 3:2; PMID:15842730; http://dx.doi.org/10.1186/1476-8518-3-2
  • Barouch DH, Stephenson KE, Borducchi EN, Smith K, Stanley K, McNally AG, Liu J, Abbink P, Maxfield LF, Seaman MS, et al. Protective efficacy of a global HIV-1 mosaic vaccine against heterologous SHIV challenges in rhesus monkeys. Cell 2013; 155:531-9; PMID:24243013; http://dx.doi.org/10.1016/j.cell.2013.09.061
  • Joensuu J, Koskenniemi E, Pang X-L, Vesikari T. Randomised placebo-controlled trial of rhesus-human reassortant rotavirus vaccine for prevention of severe rotavirus gastroenteritis. Lancet 1997; 350:1205-9; PMID:9652561; http://dx.doi.org/10.1016/S0140-6736(97)05118-0
  • Andris JS, Miller AB, Abraham SR, Cunningham S, Roubinet F, Blancher A, Capra JD. Variable region gene segment utilization in rhesus monkey hybridomas producing human red blood cell-specific antibodies: predominance of the VH4 family but not VH4-21 (V4-34). Mol Immunol 1997; 34:237-53; PMID:9224966; http://dx.doi.org/10.1016/S0161-5890(97)00021-7
  • Glamann J, Burton DR, Parren PW, Ditzel HJ, Kent KA, Arnold C, Montefiori D, Hirsch VM. Simian immunodeficiency virus (SIV) envelope-specific Fabs with high-level homologous neutralizing activity: recovery from a long-term-nonprogressor SIV-infected macaque. J Virol 1998; 72:585-92; PMID:9420262
  • Sundling C, Phad G, Douagi I, Navis M, Karlsson Hedestam GB. Isolation of antibody V(D)J sequences from single cell sorted rhesus macaque B cells. J Immunol Methods 2012; 386(1-2):85-93; PMID:22989932; http://dx.doi.org/10.1016/j.jim.2012.09.003
  • Pelat T, Thullier P. Non-human primate immune libraries combined with germline humanization: an (almost) new, and powerful approach for the isolation of therapeutic antibodies. mAbs 2009; 1:377-81; PMID:20068407; http://dx.doi.org/10.4161/mabs.1.4.8635
  • Smith K, Garman L, Wrammert J, Zheng NY, Capra JD, Ahmed R, Wilson PC. Rapid generation of fully human monoclonal antibodies specific to a vaccinating antigen. Nat Protoc 2009; 4:372-84; PMID:19247287; http://dx.doi.org/10.1038/nprot.2009.3
  • Wrammert J, Onlamoon N, Akondy RS, Perng GC, Polsrila K, Chandele A, Kwissa M, Pulendran B, Wilson PC, Wittawatmongkol O, et al. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans. J Virol 2012; 86:2911-8; PMID:22238318; http://dx.doi.org/10.1128/JVI.06075-11
  • Nakamura G, Chai N, Park S, Chiang N, Lin Z, Chiu H, Fong R, Yan D, Kim J, Zhang J, et al. An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies. Cell Host Microbe 2013; 14:93-103; PMID:23870317; http://dx.doi.org/10.1016/j.chom.2013.06.004
  • Benckert J, Schmolka N, Kreschel C, Zoller MJ, Sturm A, Wiedenmann B, Wardemann H. The majority of intestinal IgA+ and IgG+ plasmablasts in the human gut are antigen-specific. J Clin Invest 2011; 121:1946-55; PMID:21490392; http://dx.doi.org/10.1172/JCI44447
  • Corti D, Voss J, Gamblin SJ, Codoni G, Macagno A, Jarrossay D, Vachieri SG, Pinna D, Minola A, Vanzetta F, et al. A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins. Science 2011; 333:850-6; PMID:21798894; http://dx.doi.org/10.1126/science.1205669
  • Lin Z, Chiang NY, Chai N, Seshasayee D, Lee WP, Balazs M, Nakamura G, Swem LR. In vivo antigen-driven plasmablast enrichment in combination with antigen-specific cell sorting to facilitate the isolation of rare monoclonal antibodies from human B cells. Nat Protoc 2014; 9:1563-77; PMID:24901740; http://dx.doi.org/10.1038/nprot.2014.104
  • Wrammert J, Smith K, Miller J, Langley WA, Kokko K, Larsen C, Zheng NY, Mays I, Garman L, Helms C, et al. Rapid cloning of high-affinity human monoclonal antibodies against influenza virus. Nature 2008; 453:667-71; PMID:18449194; http://dx.doi.org/10.1038/nature06890
  • Demberg T, Brocca-Cofano E, Xiao P, Venzon D, Vargas-Inchaustegui D, Lee EM, Kalisz I, Kalyanaraman VS, Dipasquale J, McKinnon K, et al. Dynamics of memory B-cell populations in blood, lymph nodes, and bone marrow during antiretroviral therapy and envelope boosting in simian immunodeficiency virus SIVmac251-infected rhesus macaques. J Virol 2012; 86:12591-604; PMID:22973034; http://dx.doi.org/10.1128/JVI.00298-12
  • Moody MA, Zhang R, Walter EB, Woods CW, Ginsburg GS, McClain MT, Denny TN, Chen X, Munshaw S, Marshall DJ, et al. H3N2 influenza infection elicits more cross-reactive and less clonally expanded anti-hemagglutinin antibodies than influenza vaccination. PLoS One 2011; 6:e25797; PMID:22039424; http://dx.doi.org/10.1371/journal.pone.0025797
  • Neumann B, Klippert A, Raue K, Sopper S, Stahl-Hennig C. Characterization of B and plasma cells in blood, bone marrow, and secondary lymphoid organs of rhesus macaques by multicolor flow cytometry. J Leukoc Biol 2015; 97(1):19-30; PMID:25341725; http://dx.doi.org/10.1189/jlb.1HI0514-243R
  • Rhesus Macaque Genome S, Analysis C, Gibbs RA, Rogers J, Katze MG, Bumgarner R, Weinstock GM, Mardis ER, Remington KA, Strausberg RL, et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science 2007; 316:222-34; PMID:17431167; http://dx.doi.org/10.1126/science.1139247
  • Sholukh AM1, Mukhtar MM, Humbert M, Essono SS, Watkins JD, Vyas HK, Shanmuganathan V, Hemashettar G, Kahn M, Hu SL, et al. Isolation of Monoclonal Antibodies with Predetermined Conformational Epitope Specificity. Plos ONE 2012; 7:e38943; PMID:22737224; http://dx.doi.org/10.1371/journal.pone.0038943
  • Bible JM, Howard W, Robbins H, Dunn-Walters DK. IGHV1, IGHV5 and IGHV7 subgroup genes in the rhesus macaque. Immunogenetics 2003; 54:867-73; PMID:12671738
  • Calvas P, Apoil P, Fortenfant F, Roubinet F, Andris J, Capra D, Blancher A. Characterization of the three immunoglobulin G subclasses of macaques. Scand J Immunol 1999; 49:595-610; PMID:10354371; http://dx.doi.org/10.1046/j.1365-3083.1999.00540.x
  • Helmuth EF, Letvin NL, Margolin DH. Germline repertoire of the immunoglobulin V(H)3 family in rhesus monkeys. Immunogenetics 2000; 51:519-27; PMID:10912503; http://dx.doi.org/10.1007/s002510000170
  • Howard WA, Bible JM, Finlay-Dijsselbloem E, Openshaw S, Dunn-Walters DK. Immunoglobulin light-chain genes in the rhesus macaque I: kappa light-chain germline sequences for subgroups IGKV1, IGKV and IGKV3. Immunogenetics 2005; 57:210-8; PMID:15900492; http://dx.doi.org/10.1007/s00251-005-0794-2
  • Link JM, Hellinger MA, Schroeder HW, Jr. The Rhesus monkey immunoglobulin IGHD and IGHJ germline repertoire. Immunogenetics 2002; 54:240-50; PMID:12136335; http://dx.doi.org/10.1007/s00251-002-0468-2
  • Meng W, Pan W, Zhang AJ, Li Z, Wei G, Feng L, Dong Z, Li C, Hu X, Sun C, et al. Rapid Generation of Human-Like Neutralizing Monoclonal Antibodies in Urgent Preparedness for Influenza Pandemics and Virulent Infectious Diseases. Plos One 2013; 8:e66276; PMID:23824680; http://dx.doi.org/10.1371/journal.pone.0066276
  • Rogers KA, Richardson JP, Scinicariello F, Attanasio R. Molecular characterization of immunoglobulin D in mammals: immunoglobulin heavy constant delta genes in dogs, chimpanzees and four old world monkey species. Immunology 2006; 118:88-100; PMID:16630026; http://dx.doi.org/10.1111/j.1365-2567.2006.02345.x
  • Scinicariello F, Attanasio R. Intraspecies heterogeneity of immunoglobulin alpha-chain constant region genes in rhesus macaques. Immunology 2001; 103:441-8; PMID:11529934; http://dx.doi.org/10.1046/j.1365-2567.2001.01251.x
  • Scinicariello F, Engleman CN, Jayashankar L, McClure HM, Attanasio R. Rhesus macaque antibody molecules: sequences and heterogeneity of alpha and gamma constant regions. Immunology 2004; 111:66-74; PMID:14678200; http://dx.doi.org/10.1111/j.1365-2567.2004.01767.x
  • Howard WA, Bible JM, Finlay-Dijsselbloem E, Openshaw S, Dunn-Walters DK. Immunoglobulin light-chain genes in the rhesus macaque II: lambda light-chain germline sequences for subgroups IGLV1, IGLV2, IGLV3, IGLV4 and IGLV5. Immunogenetics 2005; 57:655-64; PMID:16189671; http://dx.doi.org/10.1007/s00251-005-0020-2
  • Diaz OL, Daubenberger CA, Rodriguez R, Naegeli M, Moreno A, Patarroyo ME, Pluschke G. Immunoglobulin kappa light-chain V, J, and C gene sequences of the owl monkey Aotus nancymaae. Immunogenetics 2000; 51:212-8; PMID:10752631; http://dx.doi.org/10.1007/s002510050034
  • Giudicelli V, Chaume D, Lefranc MP. IMGT/GENE-DB: a comprehensive database for human and mouse immunoglobulin and T cell receptor genes. Nucleic Acids Res 2005; 33:D256-261; PMID:15608191; http://dx.doi.org/10.1093/nar/gki010
  • Lefranc MP. Immunoglobulin and T cell receptor genes: IMGT(®) and the birth and rise of immunoinformatics. Front Immunol 2014; 5:22; PMID:24600447; http://dx.doi.org/10.3389/fimmu.2014.00022
  • Boon WC, Petkovic-Duran K, Zhu Y, Manasseh R, Horne MK, Aumann TD. Increasing cDNA yields from single-cell quantities of mRNA in standard laboratory reverse transcriptase reactions using acoustic microstreaming. J Vis Exp 2011;53:e3144; PMID:21775961
  • Katzmann JA, Clark RJ, Abraham RS, Bryant S, Lymp JF, Bradwell AR, Kyle RA. Serum Reference intervals and diagnostic ranges for free kappa and free lambda immunoglobulin light chains. Clin Chem 2002; 48(9):1437-44; PMID:12194920
  • Brochet X, Lefranc MP, Giudicelli V. IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res 2008; 36:W503-508; PMID:18503082; http://dx.doi.org/10.1093/nar/gkn316
  • Lefranc MP, Giudicelli V, Duroux P, Jabado-Michaloud J, Folch G, Aouinti S, Carillon E, Duvergey H, Houles A, Paysan-Lafosse T, et al. IMGT(R), the international ImMunoGeneTics information system(R) 25 years on. Nucleic Acids Res 2015; 43:D413-422; PMID:25378316; http://dx.doi.org/10.1093/nar/gku1056
  • Margolin DH, Reimann KA, Sodroski J, Karlsson GB, Tenner-Racz K, Racz P, Letvin NL. Immunoglobulin V (H) usage during primary infection of rhesus monkeys with chimeric simian-human immunodeficiency viruses. J Virol 1997; 71:8582-8591; PMID:9343216
  • Sundling C, Li Y, Huynh N, Poulsen C, Wilson R, O'Dell S, Feng Y, Mascola JR, Wyatt RT, Karlsson Hedestam GB. High-resolution definition of vaccine-elicited B cell responses against the HIV primary receptor binding site. Sci Transl Med 2012; 4(142):142ra96; PMID:22786681; http://dx.doi.org/10.1126/scitranslmed.3003752
  • Meffre E, Milili M, Blanco-Betancourt C, Antunes H, Nussenzweig MC, Schiff C. Immunoglobulin heavy chain expression shapes the B cell receptor repertoire in human B cell development. J Clin Invest 2001; 108:879-886; PMID:11560957; http://dx.doi.org/10.1172/JCI13051
  • Miqueu P, Guillet M, Degauque N, Dore JC, Soulillou JP, Brouard S. Statistical analysis of CDR3 length distributions for the assessment of T and B cell repertoire biases. Mol Immunol 2007; 44:1057-1064; PMID:16930714; http://dx.doi.org/10.1016/j.molimm.2006.06.026
  • Frolich D, Giesecke C, Mei HE, Reiter K, Daridon C, Lipsky PE, Dorner T. Secondary immunization generates clonally related antigen-specific plasma cells and memory B cells. J Immunol 2010; 185:3103-3110; PMID:20693426; http://dx.doi.org/10.4049/jimmunol.1000911
  • Walker LM, Huber M, Doores KJ, Falkowska E, Pejchal R, Julien JP, Wang SK, Ramos A, Chan-Hui PY, Moyle M, et al. Broad neutralization coverage of HIV by multiple highly potent antibodies. Nature 2011; 477:466-470; PMID:21849977; http://dx.doi.org/10.1038/nature10373
  • Wu X, Zhou T, Zhu J, Zhang B, Georgiev I, Wang C, Chen X, Longo NS, Louder M, McKee K, et al. Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing. Science 2011; 333(6049):1593-1602; PMID:21835983; http://dx.doi.org/10.1126/science.1207532
  • Iizuka A, Komiyama M, Tai S, Oshita C, Kurusu A, Kume A, Ozawa K, Nakamura Y, Ashizawa T, Yamamoto A, et al. Identification of cytomegalovirus (CMV) pp65 antigen-specific human monoclonal antibodies using single B cell-based antibody gene cloning from melanoma patients. Immunol Lett 2011; 135:64-73; PMID:20932861; http://dx.doi.org/10.1016/j.imlet.2010.09.013
  • Wilson PC, Andrews SF. Tools to therapeutically harness the human antibody response. Nat Rev Immunol 2012; 12:709-719; PMID:23007571; http://dx.doi.org/10.1038/nri3285
  • Silveira EL, Kasturi SP, Kovalenkov Y, Rasheed AU, Yeiser P, Jinnah ZS, Legere TH, Pulendran B, Villinger F, Wrammert J. Vaccine-induced plasmablast responses in rhesus macaques: Phenotypic characterization and a source for generating antigen-specific monoclonal antibodies. J Immunol Methods 2014; 416:69-83; PMID:25445326; http://dx.doi.org/10.1016/j.jim.2014.11.003
  • Gujer C, Sundling C, Seder RA, Karlsson Hedestam GB, Lore K. Human and rhesus plasmacytoid dendritic cell and B-cell responses to Toll-like receptor stimulation. Immunology 2011; 134:257-69; PMID:21977996; http://dx.doi.org/10.1111/j.1365-2567.2011.03484.x
  • Schroeder HW, Jr., Cavacini L. Structure and function of immunoglobulins. J Allergy Clin Immunol 2010; 125:S41-52; PMID:20176268; http://dx.doi.org/10.1016/j.jaci.2009.09.046
  • Shi Y, Fan X, Meng W, Deng H, Zhang N, An Z. Engagement of immune effector cells by trastuzumab induces HER2/ERBB2 downregulation in cancer cells through STAT1 activation. Breast Cancer Res 2014; 16:R33; PMID:24693969; http://dx.doi.org/10.1186/bcr3637
  • Freed DC, Tang Q, Tang A, Li F, He X, Huang Z, Meng W, Xia L, Finnefrock AC, Durr E, et al. Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine. Proc Natl Acad Sci U S A 2013; 110:E4997-5005; PMID:24297878; http://dx.doi.org/10.1073/pnas.1316517110